로딩 중…
지수 로딩 중…
MBX Biosciences, Inc. Common Stock
MBX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$43.03+3.46%
2026-06-18
Price Chart
MBX Biosciences, Inc. Common Stock+318.58%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.05B |
| Revenue | $0.00 |
| Net Income | $-87M |
| Total Assets | $453M |
| Net Assets | $438M |
| Value | |
| P/B | 4.68x |
| FCF Yield | -3.90% |
| Profitability | |
| ROE | -19.78% |
| ROA | -19.13% |
| Financial Health | |
| Debt Ratio | 3.41% |
| Total Debt | $555000.00 |
| FCF | $-80M |
| Cash | $45M |
| Current Ratio | 30.79x |
| Performance | |
| 1Y Return | 318.58% |
| 1M Return | 41.59% |
| From 52W High | -6.15% |
| 1Y MDD | -37.12% |
| Trading | |
| Volume | 791,968 shares |
| Trading Value | $34M |
| Per Share | |
| EPS | $-2.38 |
| BPS | $10.11 |